# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Evercore ISI Group analyst Cory Kasimov initiates coverage on Moderna (NASDAQ:MRNA) with a In-Line rating and announces Pric...
Meme stocks, led by Keith Gill, have resurfaced on social media, causing GameStop's stock to surge by 74% and AMC's by ...
Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.
FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.